tiotropium Respimat
Selected indexed studies
- Tiotropium. (, 2006) [PMID:30000544]
- Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease. (Drugs, 2014) [PMID:25300412]
- A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma. (Allergy Asthma Proc, 2018) [PMID:29279056]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Tiotropium/olodaterol (Stiolto Respimat) for COPD. (2015) pubmed
- [Spiolto Respimat® : tiotropium-olodaterol fixed combination for therapy of chronic obstructive pulmonary disease (COPD)]. (2016) pubmed
- Tiotropium. (2006) pubmed
- Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease. (2014) pubmed
- A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma. (2018) pubmed
- Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to Age. (2020) pubmed
- Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists. (2015) pubmed
- Pharmacokinetics of tiotropium administered by Respimat(®) in asthma patients: Analysis of pooled data from Phase II and III clinical trials. (2017) pubmed
- Burden of Asthma and Role of 2.5 µg Tiotropium Respimat(®) as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials. (2019) pubmed
- Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype. (2018) pubmed